Accessibility Menu
 
China Pharma logo

China Pharma

(NYSEMKT) CPHI

Current Price$0.63
Market Cap$3.06M
Since IPO (2002)-100%
5 Year-100%
1 Year-77%
1 Month+6%

China Pharma Financials at a Glance

Market Cap

$3.06M

Revenue (TTM)

$4.05M

Net Income (TTM)

$3.19M

EPS (TTM)

$-1.03

P/E Ratio

-0.59

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$0.63

Volume

100

Open

$0.63

Previous Close

$0.63

Daily Range

$0.63 - $0.63

52-Week Range

$0.50 - $2.65

CPHI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About China Pharma

Industry

Pharmaceuticals

Employees

231

CEO

Zhi Lin Li

Headquarters

Haikou, 570216, CN

CPHI Financials

Key Financial Metrics (TTM)

Gross Margin

-8%

Operating Margin

-80%

Net Income Margin

-79%

Return on Equity

-42%

Return on Capital

-35%

Return on Assets

-20%

Earnings Yield

-1.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.06M

Shares Outstanding

5.02M

Volume

100

Short Interest

0.00%

Avg. Volume

50.10K

Financials (TTM)

Gross Profit

$1.99M

Operating Income

$4.59M

EBITDA

$1.96M

Operating Cash Flow

$466.36K

Capital Expenditure

$291.72K

Free Cash Flow

$758.08K

Cash & ST Invst.

$626.88K

Total Debt

$3.59M

China Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$756.22K

-31.3%

Gross Profit

$59.65K

+88.5%

Gross Margin

-7.89%

N/A

Market Cap

$3.06M

N/A

Market Cap/Employee

$13.68K

N/A

Employees

224

N/A

Net Income

$651.48K

+41.7%

EBITDA

$271.40K

+29.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$3.27M

+0.6%

Accounts Receivable

$285.91K

-29.7%

Inventory

$1.67M

-33.0%

Long Term Debt

$128.26K

-91.0%

Short Term Debt

$3.44M

+33.1%

Return on Assets

-19.96%

N/A

Return on Invested Capital

-34.55%

N/A

Free Cash Flow

$237.60K

-529.7%

Operating Cash Flow

$236.99K

-404.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TTNPTitan Pharmaceuticals, Inc.
$2.34-11.36%
RDHLRedHill Biopharma Ltd.
$0.81+9.11%
KALAKALA BIO, Inc.
$0.16-5.83%
OGENOragenics, Inc.
$0.55-1.80%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About CPHI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.